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Abstract
Purpose:  To  determine  if  routine  dilated  fundus  examination  (DFE)  should  be  performed  sooner
than at  10-year  intervals  in  asymptomatic  patients.
Methods:  Records  for  all  patients  consecutively  evaluated  in  a  one-year  time  frame  were  sys-
tematically  reviewed.  Of  those  patients  who  received  initial  DFE  and  were  living  10  years  later,
records  for  sequential  DFE  were  again  evaluated  to  determine  presence  of  clinically-signiﬁcant,
peripheral  retinal  ﬁndings.  Databases  were  also  searched  in  order  to  determine  the  number  of
patients during  the  same  10-year  time  period  who  developed  vision  or  life-threatening  periph-
eral retinal  ﬁndings.  The  two  groups  were  cross-matched  to  determine  effectiveness  of  routine
DFE.
Results:  Only  10  of  592  patients  were  deemed  to  have  ‘‘clinically-signiﬁcant’’  peripheral  retinal
ﬁndings----none of  whom  developed  untoward  outcomes.  Of  the  29  new  retinal  detachments
and four  intraocular  tumors  discovered  during  ten  years  of  clinical  follow-up,  nearly  90%  were
symptomatic  at  the  time  of  discovery.  Three  detachments  and  one  tumor  were  detected  as
incidental  ﬁndings  in  asymptomatic  patients.  No  further  treatment  was  recommended  for  the
three detachments  and  the  patient  with  the  tumor  survives,  although  with  profound  loss  of
vision in  the  involved  eye.
Conclusions:  In  the  absence  of  symptoms,  routine  DFE  seems  to  have  a  very  low  yield  for
discovery of  serious  ocular  events  and  appears  to  be  ineffective  in  altering  the  course  of  inci-
dental ﬁndings.  Routine  DFE  is  not  indicated  for  older,  asymptomatic  patients----even  at  decade
intervals.  The  ﬁndings  of  this  study  should  be  prospectively  conﬁrmed  in  population-based
studies.
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Resumen
Objetivo:  Determinar  si  el  examen  rutinario  del  fondo  de  ojo  debe  realizarse  con  más  frecuencia
que a  intervalos  de  10  an˜os  en  pacientes  asintomáticos.
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Métodos:  Se  revisaron  sistemáticamente  las  historias  de  todos  los  pacientes  consecutivamente
evaluados durante  un  periodo  de  un  an˜o.  Se  volvieron  a  evaluar  las  historias  de  aquellos
pacientes  cuyo  fondo  había  sido  inicialmente  examinado,  y  que  seguían  con  vida  10  an˜os
después,  para  determinar  la  presencia  de  hallazgos  con  signiﬁcación  clínica  relativa  a  la  retina
periférica.  Se  realizó  también  una  búsqueda  en  las  bases  de  datos  para  determinar  el  número
de pacientes,  durante  el  mismo  periodo  de  10  an˜os,  que  había  desarrollado  casos  en  la  retina
periférica,  con  riesgo  de  vida  o  visión.  Se  cruzaron  los  dos  grupos  para  determinar  la  efectividad
del examen  rutinario  del  fondo  de  ojo.
Resultados:  Únicamente  10  de  entre  592  pacientes  mostraron  casos  en  la  retina  periférica
‘‘clínicamente  signiﬁcativos’’,  de  los  que  ninguno  evolucionó  inadecuadamente.  De  los  29
nuevos desprendimientos  de  retina  y  cuatro  tumores  intraoculares  descubiertos  durante  los  diez
an˜os de  seguimiento  clínico  casi  el  90%  fueron  asintomáticos  en  el  momento  de  su  descubrim-
iento. Se  detectaron  tres  desprendimientos  y  un  tumor  como  casos  incidentales  en  pacientes
asintomáticos.  No  se  recomendó  ningún  tratamiento  adicional  para  los  tres  desprendimientos,
y el  paciente  con  el  tumor  sigue  vivo,  aunque  con  una  profunda  pérdida  de  visión  en  el  ojo
afectado.
Conclusiones:  En  ausencia  de  síntomas,  el  rendimiento  del  examen  rutinario  del  fondo  de  ojo
es muy  bajo  a  la  hora  de  descubrir  eventos  oculares  serios,  revelándose  poco  eﬁcaz  para  alterar
el curso  de  los  hallazgos  incidentales.  Dicho  examen  no  está  indicado  en  pacientes  de  edad  y
asintomáticos,  incluso  a  intervalos  de  10  an˜os.  Los  hallazgos  de  este  estudio  deberán  conﬁrmarse
prospectivamente  mediante  estudios  basados  en  población.
© 2012  Spanish  General  Council  of  Optometry.  Publicado  por  Elsevier  España,  S.L.  Todos  los
derechos reservados.
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FRoutine  Dilated  Fundus  Examination  (DFE)  is  considered
y  many  eye  care  providers  to  be  the  standard  of  oph-
halmic  care1;  however,  further  clariﬁcation  is  required.  DFE
ay  be  considered  to  be  ‘‘routine’’  when  completed  in  the
bsence  of  any  symptoms  suggestive  of  acute  retinal  disease
ﬂoaters,  photopsia,  peripheral  visual  distortions,  etc.),  or
hen  performed  as  part  of  periodic  monitoring  for  chronic
phthalmic  conditions  (screening  for  diabetic  retinopathy,
tereoscopic  evaluation  of  optic  nerve  head  in  glaucoma
ollow-up,  etc.).  Although  for  these  latter  conditions,  DFEs
re  performed  systematically  and  at  periodic  intervals  to
onitor  for  ophthalmic  disease  progression,  the  necessity
f  systematic  routine  DFE  in  asymptomatic  patients  without
phthalmic  disease  has  not  been  established.
Recommendations  for  routine  ocular  examination  are
ublished  by  both  ophthalmologic  and  optometric  groups2,3;
owever,  the  frequencies  for  routine  DFE----again  in  the
bsence  of  symptoms----are  not  speciﬁed.4,5 While  routine
FE  in  the  absence  of  symptoms  may  be  inexpensive,  it  is
ot  cost-effective,6 has  a  low  yield  for  signiﬁcant  ﬁndings,7
nd  is  not  always  perceived  to  be  a  benign  event  by
atients----especially  children.8 Therefore,  it  is  in  the  inter-
st  of  both  clinicians  and  patients  to  discern  the  most
udicious  application  of  DFE  as  an  ophthalmic  procedure.
DFE  is  performed  in  order  to  assess  those  portions  of  the
eripheral  retina  that  are  unobservable  through  the  non-
ydriatic  pupil.  There  are  myriad  conditions  to  be  found
n  the  peripheral  retina,  although  very  few  of  those  ﬁnd-
ngs  can  be  considered  clinically  signiﬁcant9 and  few  are
nobservable  through  undilated  pupils.10
Through  the  important  research  work  of  Norman  Byer,
t  is  now  clinically  understood  that  common  periph-
ral  retinal  ﬁndings----lattice  degeneration,11 retinoschisis,12
n
r
d
cystic  retinal  tufts,13 asymptomatic  retinal  breaks  (even
rom  tractional  tears)14----are  largely  benign  and  do  not
equire  prophylactic  laser  retinopexy.  Retinal  pavingstone
egeneration  is  another  common  peripheral  retinal  ﬁnd-
ng  with  low  clinical  risk.15 In  the  end,  it  is  the  presence
f  patient  symptoms  that  becomes  the  most  important
rognostic  indicator  associated  with  clinically  signiﬁcant,
eripheral  retinal  ﬁndings.16
Choroidal  nevi  offer  a  clinical  challenge  of  ambiguous
onsequence.  An  estimate  of  malignant  transformation  of
horoidal  nevi  into  melanoma  has  been  assigned  an  annual
isk  of  1  in  8845,17 although  this  assignment  was  based  on
he  assumption  that  all  malignant  melanomas  arise  from
re-existing  choroidal  nevi----the validity  of  which  is  uncer-
ain.  Stratifying  nevi  by  basal  diameter  yielded  an  18%
ransformation  to  melanoma  for  those  lesions  larger  than
0  mm,18 perhaps  suggesting  the  need  for  closer  monitor-
ng  of  those  patients;  however,  patient  symptomatology
as  not  reported  in  this  study.  With  regard  to  symptoma-
ology  for  intraocular  tumors,  presymptomatic  detection
f  metastatic  uveal  melanoma  conferred  little  additional
urvival  time,  calling  into  question  the  efﬁcacy  of  earlier
etection.19
Ultimately  then,  the  purpose  of  performing  DFE  is
wo-fold:  to  determine  the  clinical  risk  of  morbidity
e.g.  vision-threatening  retinal  detachment  or  neoplasms)
r  mortality  (e.g.  life-threatening  malignant  melanoma,
etastatic  lesions)  in  the  presence  of  patient  symptoms.
ortunately,  both  of  these  conditions  are  rare.  Unfortu-
ately,  they  are  also  not  always  preventable----even  with
outine  DFE.6 It  is  the  intention  of  this  paper  to  help  better
eﬁne  the  role  of  DFE  as  a symptom-driven  procedure  for
linicians  to  employ  judiciously.
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Methods
A  single  facility’s  electronic  medical  records  database  was
searched  for  all  patients  consecutively  evaluated  in  the  eye
clinic  during  a  one-calendar-year  period  of  time.  Each  of
the  records  was  systematically  reviewed  to  form  this  retro-
spective,  consecutive,  non-comparative  case  series.  All  the
medical  records  in  this  facility  are  electronically  recorded,
stored  and  readily  available  for  review,  thus  precluding  lost
paper  charts  or  record  omissions.
Initial  record  review  determined  which  patients  received
DFE  during  1998.  At  that  time,  clinical  protocol  for
this  facility  included  DFE  for  most  patients  regardless
of  symptomatology.  Exceptions  included  problem-oriented
follow-up  appointments  for  anterior  segment  diseases,  glau-
coma,  refractive  cases,  and  some  neurological  ﬁndings  (e.g.
diplopia).  Those  not  receiving  DFE  were  excluded  from  this
review.  A  handful  of  patients  who  received  multiple  DFE  dur-
ing  that  year  (for  sequential  diabetic  retinopathy  or  AMD
follow-up)  were  counted  only  once.  All  the  1998  patients  sur-
viving  in  2008  were  then  identiﬁed  to  form  the  study  cohort.
Records  were  further  reviewed  in  order  to  determine  which
of  the  10-year  survivors  had  already  received  DFE  in  2008
or  later.  No  speciﬁc  risk  factors  were  pre-selected  for  the
initial  cohort----the  intent  was  to  determine  if  there  would
have  been  any  inherent  clinical  omissions  made  for  patients
not  receiving  sequential,  routine  DFE  after  ten  years  had
passed.
Finally,  attempts  were  made  to  communicate  with  all
the  remaining  unaccounted-for  survivors  in  order  to  repeat
DFE  after  the  decade  interval.  Those  who  declined  or
were  unavailable  for  repeat  examination  (largely  due  to
invalid  contact  information)  were  excluded  from  review.  For
patients  from  this  group  who  may  have  had  DFE  prior  to  the
conclusion  of  the  10-year  interval,  most  recent  DFE  results
were  not  carried  forward.
For  the  patients  with  initial  and  ﬁnal  records  at  least
ten  years  apart,  peripheral  retinal  ﬁndings  were  classiﬁed
as  ‘‘unremarkable’’  (i.e.  no  peripheral  ﬁndings,  what-
soever),  ‘‘remarkable’’  (for  any  peripheral  ﬁndings),  or
‘‘unable  to  grade’’  if  visualization  of  retina  was  not  possible.
‘‘Remarkable’’  peripheral  ﬁndings  were  further  divided  into
‘‘clinically  signiﬁcant’’  or  ‘‘clinically  insigniﬁcant’’  groups.
‘‘Clinically  insigniﬁcant’’  ﬁndings  represented  the  vast
majority  of  patients  and  included  lesions  involving  either
primarily  the  retinal  pigmented  epithelium  (RPE)  or  the
neurosensory  retina.  RPE-level  ﬁndings  included  window
defects,  hypertrophic  changes,  atrophic  ﬁndings,  chorioreti-
nal  scars,  retinal  pavingstone  degeneration,  etc.  Those  with
predominantly  neurosensory  retinal  ﬁndings  included  reti-
nal  lattice/snailtrack  degeneration,  white  without  pressure,
retinodialysis,  peripheral  drusen,  retinoschisis,  operculated
retinal  tears,  etc.
Those  peripheral  ﬁndings  of  potential  clinical  signiﬁcance
and  deemed  ‘‘remarkable’’  included  peripheral  choroidal
nevi  and  those  patients  who  were  status  post  scleral  buck-
ling  procedures.  For  both  of  these  cases  retinal  ﬁndings
were  judged  to  be  too  anterior  in  location  to  be  observ-
able  through  non-mydriatic  pupils.  Complete  stratiﬁcation
of  patients  is  provided  in  Fig.  1.
Final  observations  included  whether  any  of  the  patients
with  ‘‘remarkable’’  peripheral  retinal  ﬁndings  developed
t
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Figure  1  Stratiﬁcation  of  study  patients.
ny  untoward  peripheral  retinal  outcomes  during  the  follow-
p  period.
Ophthalmic  ICD-9  codes  were  searched  to  reveal  all
acility  patients  who  developed  retinal  detachment  (361
eries)  or  posterior  segment  melanoma  (190  series)  during
he  same  ten-year  follow-up  period  (1998--2008).  Each  of
hese  records  was  reviewed  in  order  to  determine  patient
ymptomatology  at  the  time  of  initial  diagnosis  and  cross-
eferenced  to  the  original  cohort  in  order  to  determine  if
equential  DFE  was  useful  in  identifying  these  patients.
esults
 total  of  2184  patients  were  examined  during  the  1998  cal-
ndar  year.  Of  those  patients,  1603  (73%  of  original  cohort)
eceived  DFE.  874  of  those  patients  (55%  of  DFE  patients)
ere  surviving  and  eligible  for  sequential  DFE  after  a  ten-
ear  interval.  Of  the  874  subjects  available  for  potential
eview,  retinal  ﬁndings  for  592  patients  (68%  of  surviving  DFE
atients),  were  available  for  ﬁnal  evaluation.  The  remaining
82  patients  either  declined  repeat  examination  or  did  not
ave  valid  contact  information  and  were  unreachable  by
elephone  or  standard  mail.
For  the  592  patients  with  initial  and  ﬁnal  records  ten
ears  apart,  peripheral  retinal  ﬁndings  were  classiﬁed  as
‘unremarkable’’  for  69%  (411/592)  of  the  study  cohort  and
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‘remarkable’’  for  30%  (176/592)  of  patients.  The  remaining
 patients  (<1%,  5/592)  were  ‘‘ungradable’’  at  decade’s  end.
ocus  was  then  placed  on  the  176  patients  deemed  to  have
‘remarkable’’  peripheral  retinal  ﬁndings.
‘‘Clinically  insigniﬁcant’’  retinal  ﬁndings  were  docu-
ented  for  most  of  the  ‘‘remarkable’’  group  (166/176  or
4%  of  this  set)  after  10  years  of  follow-up.  The  remaining
0  patients  (10/592,  or  <2%  of  original  cohort)  were  deemed
o  be  ‘‘clinically  signiﬁcant.’’  These  cases  were  found  to
ave  peripheral  choroidal  nevi  (n  =  6)  or  were  status  post  RD
epairs  (n  =  4),  although  in  each  of  these  cases  the  patient
as  asymptomatic  at  time  of  DFE.  Only  one  of  the  six
atients  with  choroidal  nevi  demonstrated  a  large  periph-
ral  nevus  (>10  mm  in  basal  diameter),  and  this  lesion  had
o  demonstrable  morphological  change  during  the  follow-up
eriod.  It  should  be  noted  that  none  of  these  ten  patients
eveloped  consequential  ophthalmic  events,  and  that  they
ll  remained  asymptomatic  of  peripheral  retinal  ﬁndings
hroughout  the  follow-up  period.
Five  patients  were  classiﬁed  as  ‘‘ungradable’’  due  to
rofound  ocular  ﬁndings  in  at  least  one  eye  that  pre-
luded  bilateral  10-year  sequential  DFE  (2  mature  cataracts,
orneal  leukoma,  2  phthisis  bulbi).  For  each  of  these
atients  it  should  be  noted  that  fellow  eye  DFE  was  unre-
arkable  and  B-scan  ultrasonography  did  not  suggest  any
emarkable  posterior  segment  ﬁndings.  These  ﬁve  patients
ere  not  included  in  ﬁnal  calculations.
For  the  same  10-year  time-frame,  29  new  retinal  detach-
ents  were  diagnosed.  26  of  these  were  symptomatic,
ncluding  central  or  peripheral  visual  symptoms  with  ﬂoaters
nd/or  photopsia.  The  three  new-onset,  asymptomatic  RDs
ere  all  delimited  in  nature,  and  all  occurred  as  inciden-
al  ﬁndings  in  eyes  without  functional  vision  (previous  RD,
RVO,  advanced  AMD).  None  of  these  three  cases  were  ulti-
ately  treated  after  retinal  consultation.
There  were  four  new  intraocular  tumors  identiﬁed  during
he  period  of  regard:  three  melanomas  and  one  metastatic
veal  tumor.  Of  these,  three  were  symptomatic  (primarily
ith  peripheral  visual  ﬁeld  changes),  and  one  was  entirely
n  incidental  ﬁnding.  This  eye----diagnosed  with  choroidal
elanoma----ultimately  developed  Light  Perception  vision
espite  immediate  brachytherapy.  The  patient  survived
fter  ﬁve  years  of  follow-up.
onclusions
ntuitively,  the  inherent  risk  of  ‘‘missing’’  clinically  signiﬁ-
ant  peripheral  retinopathy  must  be  low  when  considering
he  history  of  optometry  prior  to  the  widespread  use  of
iagnostic  pharmaceutical  agents.  Millions  of  undilated  eye
xaminations  were  performed  by  optometrists,  yet  periph-
ral  retinal  pathologies  of  clinical  import  did  not  reach
pidemic  proportions.  This  review  seems  to  provide  a  clini-
al  basis  for  this  observation.
These  results  are  limited  by  the  same  challenges  that
ace  all  retrospective  studies  (i.e.  accuracy  of  medical
ecords,  difﬁculties  in  controlling  for  confounders/bias,
ypothesis  generating  only20);  however,  it  is  the  best  way
o  evaluate  conditions  of  rare  occurrence.  The  high  rate  of
ttrition  from  the  original  group  of  patients  in  terms  of  sur-
ival  rate  (only  55%  of  original  DFE  cohort  was  living  tenP.  Varner
ears  after  initial  DFE),  is  highly  related  to  the  study  popula-
ion  (the  average  age  of  patients  in  this  facility  is  70  years  of
ge  [internal  data],  and  predominantly  male)  and  suggests
hat  DFE  near  the  end  of  life  may  be  even  less  clinically
onsequential.  Nearly  one-third  of  the  eligible  cohort  (32%
f  874)  was  not  re-examined,  thus  introducing  real  possibil-
ties  of  selection  bias.  Another  potential  source  of  selection
ias  could  be  from  the  choice  of  the  initial  cohort.  Inclusion
f  all  the  patients  examined  during  a  single,  calendar  year
as  chosen  in  order  to  eliminate  possible  bias  from  exclusion
riteria  noted  in  earlier  studies  of  DFE.  These  shortcomings
re  acknowledged  and  it  is  recognized  that  these  results  may
r  may  not  be  generalizable  to  a  population  including  all
ges  of  patients.
However,  these  results  must  be  understood  within  the
ontext  of  the  very  low  risks  associated  with  various
eripheral  ophthalmic  conditions11--15 and  the  low  yield  of
‘clinically  signiﬁcant’’  peripheral  retinal  ﬁndings  on  initial
outine  DFE.10 This  review’s  ﬁnding  that  the  identiﬁcation  of
 single  retinal  ﬁnding  of  clinical  importance  in  an  asymp-
omatic  patient  out  of  ten  years  of  follow-up  of  592  older
atients----and  that  the  outcome  of  that  single  case  was  not
ltered  by  presymptomatic  diagnosis----conﬁrms  earlier  sug-
estions  that  the  ‘‘value’’  of  routine  DFE  remains  low.6 This
tudy  fails  to  disprove  that  null  hypothesis.
The  dangling  implication  of  this  report  is  that  it  remains
ntirely  possible  that  an  older,  asymptomatic  patient  may
ever  require  DFE  during  the  course  of  his  or  her  life.  Long-
erm  prospective,  population-based  study  is  required  to
ollow  up  on  this  intriguing  hypothesis  and  to  provide  medi-
al  evidence  to  substantiate  an  old  clinical  practice.  In  the
nal  analysis,  patient  symptomatology  continues  to  be  the
ingle  most  important  factor  in  discovering  highly  signiﬁcant
eripheral  retinal  ﬁndings.  To  answer  the  question  posed  by
he  title  of  this  article  then,  clinicians  must  recognize  that
t  is  quite  possibly  ‘‘never.’’
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